Fresh Day Meds review
Compounded semaglutide and tirzepatide sold on plan tiles that print the dose and renewal term, though the advertised $99 headline is a starter-dose, three-month prepaid rate.
- Semaglutide
- $140/mo any dose
- Tirzepatide
- $179/mo any dose
- Coverage
- 48 states
- Brand-name
- Compounded only
The scorecard
Fresh Day Meds scored on our six published factors. See the methodology.
What we like
- Every pricing tile prints its dose range and renewal term, e.g. '$99/mo' shows '0.22 / 0.44 / 0.88 mg' and '$299 quarterly renewal'
- A genuine month-to-month option exists at $140/mo semaglutide and $179/mo tirzepatide with any standard dose through 15 mg
- 'No membership fees' stated on the homepage; free expedited shipping and '$0 until approved' before clinical review
- Operating entity disclosed as Fresh Day Meds, LLC with the medical group named as Telegra MD LLC, Spokane, Washington
- Terms of service enumerate coverage state by state rather than claiming vague nationwide reach
The caveats
- The '$99/mo' and '$140/mo' headlines carry two qualifiers at once: starter doses only, and a three-month prepaid bundle billed quarterly
- Compounded semaglutide and tirzepatide are not FDA-approved finished drug products and have not been reviewed by FDA for safety or efficacy
- Compounded only; no brand Wegovy, Zepbound, Ozempic or Mounjaro fallback and no oral GLP-1
- Compounding pharmacy partner is not named anywhere, only generic '503A and 503B' language
- Compounded GLP-1 is excluded in Arkansas and Virginia despite marketing that reads as nationwide
The verdict
Best for: Buyers who want the dose and billing term printed beside every price before they hand over a card. Compounded semaglutide and tirzepatide sold on plan tiles that print the dose and renewal term, though the advertised $99 headline is a starter-dose, three-month prepaid rate.
Ranked #305 of 539 providers we have reviewed — for comparison, read what CoreAge Rx scores, and why, our #1 pick. In the ranking it sits between MyStart Health at #304, 63/100 above and Trillium Meds at #306, 63/100 below, with the EdgeRx ruling the next one down.
If that ruling leaves you undecided, the 7 programs we rank against Fresh Day Meds are graded on the same six factors and listed in score order.If you would rather start from the top of the field, our full board of 539 providers is the place to start if you are still shortlisting. We have also ruled on it directly: CoreAge Rx vs Fresh Day Meds goes to CoreAge Rx, 94/100 to 63/100.
Compare with other providers
The closest rulings to Fresh Day Meds by Verdict Score — the realistic shortlist if you are weighing this one up.
- #300Vital Edge— Vital Edge is a Chattanooga, TN telehealth practice offering physician-supervised GLP-1 weight loss nationwide by video, with medication shipped to your door each month.64/100
- #301Youth & Soul— Ten-vertical telehealth marketplace selling compounded GLP-1 tiers alongside HRT, ED, nootropics and peptides, running on the Bask Health platform.64/100
- #302Aquivia Health— Aquivia Health is a clinician-led, self-pay telehealth platform offering compounded GLP-1 therapy with the option to step up to branded Ozempic or Zepbound — an unusual side-by-side most compounded…64/100
- #303Lttl— A deep compounded menu — injectable, oral tablet and microdose — with a full public price matrix, and four pharmacies named in the Terms rather than on any product page.61/100
- #304MyStart Health— A fast-onboarding compounded GLP-1 service with a genuine dose price-lock, undermined by quiz-gated pricing, unnamed pharmacies and an FDA warning letter from September 2025.63/100
- #306Trillium Meds— A one-person Portland operation reselling compounded GLP-1s through two named pharmacies, both of which carry live FDA enforcement history. Pricing is published and honest.63/100
Pricing, states and verification reflect Fresh Day Meds's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Fresh Day Meds's site. Not medical advice; see our disclosure.